Inosine 5'-Monophosphate Dehydrogenase (IMPDH) Activity in Children: Physiological Regulation and Response to Mycophenolic Acid (MPA) Therapy

被引：0
|
作者：
Rother, A. [1 ]
Glander, P. [3 ]
Vitt, E. [2 ]
von Ahsen, N.
Armstrong, V.
Oellerich, M.
Budde, K. [3 ]
Toenshoff, B. [1 ]
Weber, L. T. [2 ]
机构：
[1] Univ Childrens Hosp, Heidelberg, Germany
[2] Univ Childrens Hosp, Munich, Germany
[3] Univ Hosp, Berlin, Germany
来源：
PEDIATRIC NEPHROLOGY | 2010年 / 25卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
511
引用
收藏
页码：1896 / 1896
页数：1
相关论文
共 50 条
  • [41] An inosine 5′-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid
    W Winnicki
    G Weigel
    G Sunder-Plassmann
    T Bajari
    B Winter
    H Herkner
    G Sengoelge
    The Pharmacogenomics Journal, 2010, 10 : 70 - 76
  • [42] An inosine 5′-monophosphate dehydrogenase 2 single-nucleotide polymorphism impairs the effect of mycophenolic acid
    Winnicki, W.
    Weigel, G.
    Sunder-Plassmann, G.
    Bajari, T.
    Winter, B.
    Herkner, H.
    Sengoelge, G.
    PHARMACOGENOMICS JOURNAL, 2010, 10 (01): : 70 - 76
  • [43] The inhibition of human inosine monophosphate dehydrogenase by mycophenolic acid glucuronide is due to the presence of trace quantities of mycophenolic acid.
    Korecka, M
    van Breeman, RB
    Shaw, LM
    CLINICAL CHEMISTRY, 1998, 44 : A101 - A101
  • [44] Inosine monophosphate dehydrogenase activity depends on plasma concentrations of mycophenolic acid and its glucuronides in kidney transplant recipients
    Mino, Yasuaki
    Naito, Takafumi
    Otsuka, Atsushi
    Ozono, Seiichiro
    Kagawa, Yoshiyuki
    Kawakami, Junichi
    CLINICA CHIMICA ACTA, 2009, 409 (1-2) : 56 - 61
  • [45] Abacavir and mycophenolic acid, an inhibitor of inosine monophosphate dehydrogenase, have profound and synergistic anti-HIV activity
    Margolis, D
    Heredia, A
    Gaywee, J
    Oldach, D
    Drusano, G
    Redfield, R
    JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 1999, 21 (05): : 362 - 370
  • [46] The use of mycophenolic acid, an inosine monophosphate dehydrogenase inhibitor, as part of salvage therapy in late stage HIV disease
    Toukas, CM
    Hatzakis, GE
    AIDS, 2000, 14 : S20 - S20
  • [47] Pharmacodynamic assessment of mycophenolic acid-induced immunosuppression by measurement of inosine monophosphate dehydrogenase activity in a canine model
    Langman, LJ
    Shapiro, AMJ
    Lakey, JRT
    LeGatt, DF
    Kneteman, NM
    Yatscoff, RW
    TRANSPLANTATION, 1996, 61 (01) : 87 - 92
  • [48] A putative role for inosine 5′ monophosphate dehydrogenase (IMPDH) in Leishmania amazonensis programmed cell death
    Pitaluga, A. N.
    Moreira, M. E. C.
    Traub-Csekoe, Y. M.
    EXPERIMENTAL PARASITOLOGY, 2015, 149 : 32 - 38
  • [49] Non-radioactive determination of inosine 5′-monophosphate dehydrogenase (IMPDH) in peripheral mononuclear cells
    Glander, P
    Braun, KP
    Hambach, P
    Bauer, S
    Mai, I
    Roots, I
    Waiser, J
    Fritsche, L
    Neumayer, HH
    Budde, K
    CLINICAL BIOCHEMISTRY, 2001, 34 (07) : 543 - 549
  • [50] Inosine 5′-Monophosphate Dehydrogenase (IMPDH) as a Potential Target for the Development of a New Generation of Antiprotozoan Agents
    Fotie, Jean
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2018, 18 (08) : 656 - 671
12345